Apollon Formularies (AQSE:APOL) Scaled Net Operating Assets : 0.56 (As of Jun. 2023)

View and export this data going back to . Start your Free Trial

What is Apollon Formularies Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Apollon Formularies's operating assets for the quarter that ended in Jun. 2023 was £3.91 Mil. Apollon Formularies's operating liabilities for the quarter that ended in Jun. 2023 was £1.84 Mil. Apollon Formularies's Total Assets for the quarter that ended in Jun. 2022 was £3.66 Mil. Therefore, Apollon Formularies's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2023 was 0.56.

Apollon Formularies Scaled Net Operating Assets Historical Data

The historical data trend for Apollon Formularies's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apollon Formularies Scaled Net Operating Assets Chart

Apollon Formularies Annual Data

Trend

Jun10

Jun11

Dec12

Dec13

Dec14

Dec17

Dec18

Dec19

Dec20

Dec21

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.67

0.61

-0.19

1.81

1.11

Apollon Formularies Semi-Annual Data
	Jun11	Jun12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec17	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Jun23
Scaled Net Operating Assets	Get a 7-Day Free Trial											-	1.02	0.69	1.00	0.56

Competitive Comparison of Apollon Formularies's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Apollon Formularies's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Apollon Formularies's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Apollon Formularies's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Apollon Formularies's Scaled Net Operating Assets falls into.

Apollon Formularies Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Apollon Formularies's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2021 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2021 )
=	(Operating Assets (A: Dec. 2021 )	-	Operating Liabilities (A: Dec. 2021 ))	/	Total Assets (A: Dec. 2020 )
=	(2.741	-	0.083)	/	2.401
=	1.11

where

	Operating Assets		(A: Dec. 2021 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	3.046	-	0.305
=	2.741

	Operating Liabilities		(A: Dec. 2021 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	0.083	-	0	-	0
=	0.083

Apollon Formularies's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jun. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Jun. 2023 )
=	(Operating Assets (Q: Jun. 2023 )	-	Operating Liabilities (Q: Jun. 2023 ))	/	Total Assets (Q: Jun. 2022 )
=	(3.906	-	1.842)	/	3.658
=	0.56

where

	Operating Assets		(Q: Jun. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	3.957	-	0.051
=	3.906

	Operating Liabilities		(Q: Jun. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	1.842	-	0	-	0
=	1.842

Apollon Formularies Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Apollon Formularies's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Apollon Formularies (AQSE:APOL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Apollon Formularies PLC (AQSE:APOL) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

6 Hope Street, Quayside House, Castletown, IMN, IM9 1AS

Website

https://www.apollon.org.uk

Apollon Formularies PLC is a London, England and Jamaican based medical cannabis pharmaceutical company specialising in research and treatment of patients with cancer and chronic pain. It is engaged in investing by seeking to acquire a direct and/or indirect interest in projects and assets in the agriculture and logistics sectors and the medicinal cannabis sector. The company focus on opportunities in Africa and Europe. It has created proprietary hybrid medical cannabis pharmaceutical strains, technology, formulations, and treatment products.